IBBQ holdings
Invesco Nasdaq Biotechnology ETF
Positions
261 stored of 261 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 201 | Kamada Ltd. | IL0010941198 | M6240T109 | 0.035% | $24K | Equity (common) | Corporate | Israel | USD |
| 202 | Neurogene Inc. | US64135M1053 | 64135M105 | 0.035% | $24K | Equity (common) | Corporate | United States | USD |
| 203 | Upstream Bio, Inc. | US91678A1079 | 91678A107 | 0.035% | $24K | Equity (common) | Corporate | United States | USD |
| 204 | Pacific Biosciences of California, Inc. | US69404D1081 | 69404D108 | 0.035% | $24K | Equity (common) | Corporate | United States | USD |
| 205 | First Tracks Biotherapeutics, Inc. | US3371851029 | 337185102 | 0.035% | $23K | Equity (common) | Corporate | United States | USD |
| 206 | Lakefront Biotherapeutics N.V. Lakefront Biotherapeutics N.V., ADR | US36315X1019 | 36315X101 | 0.033% | $23K | Equity (common) | Corporate | Belgium | USD |
| 207 | C4 Therapeutics, Inc. | US12529R1077 | 12529R107 | 0.033% | $22K | Equity (common) | Corporate | United States | USD |
| 208 | Evolus, Inc. | US30052C1071 | 30052C107 | 0.033% | $22K | Equity (common) | Corporate | United States | USD |
| 209 | Contineum Therapeutics, Inc. Contineum Therapeutics, Inc., Class A | US21217B1008 | 21217B100 | 0.032% | $22K | Equity (common) | Corporate | United States | USD |
| 210 | OmniAb, Inc. | US68218J1034 | 68218J103 | 0.030% | $20K | Equity (common) | Corporate | United States | USD |
| 211 | Altimmune, Inc. | US02155H2004 | 02155H200 | 0.030% | $20K | Equity (common) | Corporate | United States | USD |
| 212 | Vanda Pharmaceuticals Inc. | US9216591084 | 921659108 | 0.030% | $20K | Equity (common) | Corporate | United States | USD |
| 213 | Enanta Pharmaceuticals, Inc. | US29251M1062 | 29251M106 | 0.030% | $20K | Equity (common) | Corporate | United States | USD |
| 214 | Larimar Therapeutics, Inc. | US5171251003 | 517125100 | 0.030% | $20K | Equity (common) | Corporate | United States | USD |
| 215 | Lexeo Therapeutics, Inc. | US52886X1072 | 52886X107 | 0.029% | $20K | Equity (common) | Corporate | United States | USD |
| 216 | Autolus Therapeutics PLC Autolus Therapeutics PLC, ADR | US05280R1005 | 05280R100 | 0.029% | $20K | Equity (common) | Corporate | United Kingdom | USD |
| 217 | Immuneering Corp. Immuneering Corp., Class A | US45254E1073 | 45254E107 | 0.029% | $20K | Equity (common) | Corporate | United States | USD |
| 218 | Lyell Immunopharma, Inc. | US55083R2031 | 55083R203 | 0.029% | $19K | Equity (common) | Corporate | United States | USD |
| 219 | Atea Pharmaceuticals, Inc. | US04683R1068 | 04683R106 | 0.029% | $19K | Equity (common) | Corporate | United States | USD |
| 220 | Puma Biotechnology, Inc. | US74587V1070 | 74587V107 | 0.029% | $19K | Equity (common) | Corporate | United States | USD |
| 221 | Cabaletta Bio, Inc. | US12674W1099 | 12674W109 | 0.029% | $19K | Equity (common) | Corporate | United States | USD |
| 222 | REGENXBIO Inc. | US75901B1070 | 75901B107 | 0.028% | $19K | Equity (common) | Corporate | United States | USD |
| 223 | Keros Therapeutics, Inc. | US4923271013 | 492327101 | 0.027% | $18K | Equity (common) | Corporate | United States | USD |
| 224 | Editas Medicine, Inc. | US28106W1036 | 28106W103 | 0.026% | $18K | Equity (common) | Corporate | United States | USD |
| 225 | SIGA Technologies, Inc. | US8269171067 | 826917106 | 0.026% | $18K | Equity (common) | Corporate | United States | USD |
| 226 | Rocket Pharmaceuticals, Inc. | US77313F1066 | 77313F106 | 0.026% | $18K | Equity (common) | Corporate | United States | USD |
| 227 | Silence Therapeutics PLC Silence Therapeutics PLC, ADR | US82686Q1013 | 82686Q101 | 0.025% | $17K | Equity (common) | Corporate | United Kingdom | USD |
| 228 | Invivyd, Inc. | US00534A1025 | 00534A102 | 0.025% | $17K | Equity (common) | Corporate | United States | USD |
| 229 | Neumora Therapeutics, Inc. | US6409791000 | 640979100 | 0.024% | $16K | Equity (common) | Corporate | United States | USD |
| 230 | Alpha Teknova, Inc. | US02080L1026 | 02080L102 | 0.023% | $15K | Equity (common) | Corporate | United States | USD |
| 231 | Anavex Life Sciences Corp. | US0327973006 | 032797300 | 0.022% | $15K | Equity (common) | Corporate | United States | USD |
| 232 | Entrada Therapeutics, Inc. | US29384C1080 | 29384C108 | 0.021% | $14K | Equity (common) | Corporate | United States | USD |
| 233 | AC Immune S.A. | CH0329023102 | H00263105 | 0.021% | $14K | Equity (common) | Corporate | Switzerland | USD |
| 234 | Humacyte, Inc. | US44486Q1031 | 44486Q103 | 0.020% | $13K | Equity (common) | Corporate | United States | USD |
| 235 | Codexis, Inc. | US1920051067 | 192005106 | 0.020% | $13K | Equity (common) | Corporate | United States | USD |
| 236 | Foghorn Therapeutics Inc. | US3441741077 | 344174107 | 0.020% | $13K | Equity (common) | Corporate | United States | USD |
| 237 | LENZ Therapeutics, Inc. | US52635N1037 | 52635N103 | 0.019% | $13K | Equity (common) | Corporate | United States | USD |
| 238 | Coherus Oncology, Inc. | US19249H1032 | 19249H103 | 0.019% | $13K | Equity (common) | Corporate | United States | USD |
| 239 | Quantum-Si Inc. | US74765K1051 | 74765K105 | 0.018% | $12K | Equity (common) | Corporate | United States | USD |
| 240 | Voyager Therapeutics, Inc. | US92915B1061 | 92915B106 | 0.018% | $12K | Equity (common) | Corporate | United States | USD |
| 241 | Sagimet Biosciences Inc. Sagimet Biosciences Inc., Class A | US7867001049 | 786700104 | 0.018% | $12K | Equity (common) | Corporate | United States | USD |
| 242 | Arcturus Therapeutics Holdings Inc. | US03969T1097 | 03969T109 | 0.018% | $12K | Equity (common) | Corporate | United States | USD |
| 243 | Orchestra Biomed Holdings, Inc. | US68572M1062 | 68572M106 | 0.017% | $12K | Equity (common) | Corporate | United States | USD |
| 244 | Caribou Biosciences, Inc. | US1420381089 | 142038108 | 0.017% | $12K | Equity (common) | Corporate | United States | USD |
| 245 | Bicycle Therapeutics PLC Bicycle Therapeutics PLC, ADR | US0887861088 | 088786108 | 0.017% | $11K | Equity (common) | Corporate | United Kingdom | USD |
| 246 | NovaBridge Biosciences NovaBridge Biosciences, ADR | US44975P1030 | 44975P103 | 0.016% | $11K | Equity (common) | Corporate | Cayman Islands | USD |
| 247 | Tenaya Therapeutics, Inc. | US87990A1060 | 87990A106 | 0.015% | $10K | Equity (common) | Corporate | United States | USD |
| 248 | Lifecore Biomedical, Inc. | US5147661046 | 514766104 | 0.015% | $10K | Equity (common) | Corporate | United States | USD |
| 249 | Jyong Biotech Ltd. | KYG831161065 | G83116106 | 0.013% | $9K | Equity (common) | Corporate | Cayman Islands | USD |
| 250 | Black Diamond Therapeutics, Inc. | US09203E1055 | 09203E105 | 0.010% | $7K | Equity (common) | Corporate | United States | USD |
| 251 | Pyxis Oncology, Inc. | US7473241013 | 747324101 | 0.009% | $6K | Equity (common) | Corporate | United States | USD |
| 252 | PepGen Inc. | US7133171055 | 713317105 | 0.008% | $5K | Equity (common) | Corporate | United States | USD |
| 253 | Invesco Government & Agency Portfolio Invesco Government & Agency Portfolio, Institutional Class | US8252528851 | 825252885 | 0.008% | $5K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 254 | Rani Therapeutics Holdings, Inc. Rani Therapeutics Holdings, Inc., Class A | US7530181004 | 753018100 | 0.007% | $5K | Equity (common) | Corporate | United States | USD |
| 255 | Aardvark Therapeutics, Inc. | US0029421007 | 002942100 | 0.007% | $5K | Equity (common) | Corporate | United States | USD |
| 256 | Gossamer Bio, Inc. | US38341P1021 | 38341P102 | 0.004% | $3K | Equity (common) | Corporate | United States | USD |
| 257 | Cartesian Therapeutics, Inc. Cartesian Therapeutics, Inc., Rts., 2050-12-31 | US8162121128 | 816212112 | <0.001% | $359 | Equity (common) | Corporate | United States | USD |
| 258 | OmniAb, Inc. OmniAb, Inc., Rts., expiring 2027-11-02 | US68218J3014 | 68218J301 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 259 | OmniAb, Inc. OmniAb, Inc., Rts., 2027-11-02 | US68218J2024 | 68218J202 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 260 | Third Harmonic Bio, Inc. Third Harmonic Bio, Inc., Class B | US88427A1079 | 88427A107 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 261 | Novo Nordisk A/S | Not reported | 009CVR044 | 0.000% | $0 | Equity (common) | Corporate | Denmark | USD |